相关实验视频

Updated: Jul 3, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

在小儿心力衰竭中使用心室辅助器件后,皮内素系统的变化

Rosetta Ragusa¹, Arianna Di Molfetta², Alberto Mercatanti¹

¹Institute of Clinical Physiology, CNR, Pisa, Italy.

|February 15, 2024

概括

在儿科心力衰竭 (HF) 患者中植入心室辅助器件 (VAD) 对microRNAs (miRNAs) 和adiponectin系统产生影响. 特定的miRNAs调节心脏受体,表明改善心脏功能的潜在治疗点.

科学领域:

心脏病学心脏病学
分子生物学分子生物学
儿科医学儿科医学

背景情况:

儿科末期心力衰竭 (HF) 用心室辅助器件 (VAD) 治疗.
VADs可以改变HF中的分子通路,包括微RNA (miRNA) 表达.
阿迪波涅丁 (ADPN) 系统以其心脏保护作用而闻名.

研究的目的:

为了研究VAD修饰的miRNAs对儿科HF患者的阿迪波内克丁系统的影响.
探索心脏中ADPN系统组件的潜在miRNA介导调节.

主要方法:

在VAD植入之前和之后,在儿科HF患者和健康对照中测量了血ADPN水平.
在VAD前和之后的心脏活检分析了miRNA配置文件和ADPN系统分子.
使用HL-1细胞的体外研究评估了特定miRNAs在ADPN系统组件上的调节作用.

主要成果:

植入VAD并没有改变循环或心脏ADPN水平.
ADPN受体 (AdipoR1,AdipoR2,T-cad) 的心脏mRNA表达在VAD后增加.
阿迪波R2和T-cad表达与VAD修饰的miRNA水平 (miR-1246,miR-199b-5p) 反向相关.
在体外研究证实miR-1246和miR-199b-5p调节阿迪波R2,miR-199b-5p调节T-cad.

结论:

VAD治疗可以通过像miRNAs这样的表观遗传媒介调节心脏保护性ADPN系统.
特定的miRNAs (miR-1246,miR-199b-5p) 似乎调节ADPN系统的关键组成部分.
miRNAs代表了增强VADs治疗的儿科HF患者心脏功能的潜在治疗点.

关键词:

这就是VAD VAD.亚迪波尼克丁系的系统.心脏衰竭是因为心脏衰竭.这是一个小RNARNA.儿科患者的儿童患者.

更多相关视频

Author Spotlight: Establishment and Confirmation of a Postnatal Right Ventricular Volume Overload Mouse Model

Author Spotlight: Establishment and Confirmation of a Postnatal Right Ventricular Volume Overload Mouse Model

Published on: June 9, 2023

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

相关概念视频

Pathophysiology of Heart Failure

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...